 Okay, I want to acknowledge that we have disagreement, fundamental disagreement, both about the numbers and how to interpret them, but move on to some other questions. Is there legal precedent for second-guessing the FDA in this way? And if, in the end, the alliance prevails in this case, what would be the implication and the impact on all agencies more broadly? I'll take that to you first, Catherine, please.